The difference lies in clinical depth: a board-certified obesity medicine physician understands the complex interplay between metabolic hormones, body composition, pharmacokinetics, nutritional science, and behavioral psychology
BPC-157 appears on the WADA Prohibited List under the S0 Non-Approved Substances category
The luteinizing hormone receptor and steroidogenesis in Leydig cells. Endocrine Reviews , 19(2), 187223
Losing muscle can lead to a lower metabolic rate , making it harder to maintain long-term weight loss
The practical aspects of using these compounds differ in ways that affect your day-to-day experience
Liraglutide (Saxenda): The Original Weight Loss GLP-1 Liraglutide was the first GLP-1 receptor agonist to receive FDA approval specifically for chronic weight management, doing so in 2014 under the brand name Saxenda